Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples